NCT05562232 is a NA clinical trial of Creatine Monohydrate in Mild Traumatic Brain Injury, sponsored by Psychiatric Research Unit, Region Zealand, Denmark.

Who is sponsoring NCT05562232?

NCT05562232 is sponsored by Psychiatric Research Unit, Region Zealand, Denmark.

What drugs are being tested in NCT05562232?

Interventions in NCT05562232: Creatine Monohydrate.

What condition does NCT05562232 study?

NCT05562232 studies Mild Traumatic Brain Injury, Concussion, Brain.

Is NCT05562232 still recruiting?

NCT05562232 is currently recruiting now. Last updated 12 July 2024.

Last reviewed 2024-07-12 · How we verify

NCT05562232

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Creatine Monohydrate on Persistent Post-concussive Symptoms

Recruiting now NA Last updated 12 July 2024

What this trial tests

NA trial testing Creatine Monohydrate in Mild Traumatic Brain Injury in 45 participants. Currently enrolling.

Timeline

1 August 2023

Primary endpoint
31 August 2024

31 December 2024

Quick facts

Lead sponsor	Psychiatric Research Unit, Region Zealand, Denmark
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	45
Start date	1 August 2023
Primary completion	31 August 2024
Estimated completion	31 December 2024
Sites	1 location across Denmark

Drugs / interventions tested

Creatine Monohydrate — full drug profile →

Conditions studied

Mild Traumatic Brain Injury — all drugs for Mild Traumatic Brain Injury →
Concussion, Brain — all drugs for Concussion, Brain →

Sponsor

Psychiatric Research Unit, Region Zealand, Denmark

Who can join

Adults 20 to 45, any sex, with Mild Traumatic Brain Injury or Concussion, Brain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study, is to investigate whether creatine monohydrate as a supplement reduces the number and severity of symptoms in patients with persistent post-concussive symptoms through self-reported post-concussion symptoms questionnaires.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Part II. Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show?
Antonio J, Brown AF, Candow DG, Chilibeck PD, et al · · 2025 · cited 12× · PMID 39720835 · DOI 10.1080/15502783.2024.2441760
Pilot study protocol of a randomized controlled trial for the potential effects of creatine monohydrate on persistent post-concussive symptoms.
Bødker RL, Marcussen M. · · 2023 · cited 2× · PMID 37475743 · DOI 10.3389/fneur.2023.1209548

Verify or expand the search:

Other trials of Creatine Monohydrate

Trials testing the same drug.

NCT07275996 — Neuromuscular and Multi-Omics Synergy of Combined Creatine × HMB Supplementation Plus Exercise to Improve Muscle Functio · NA · not yet recruiting
NCT07475676 — Effects of Short-term Acute Creatine Supplementation on Power, Speed and Muscular Strengths in Young Football Players · NA · not yet recruiting
NCT07534293 — Effects of 7-Day Creatine Supplementation on Cognitive Function After High-Intensity Interval Training in Active Young M · NA · completed
NCT07225335 — Impact of OptiCreatine on Plasma Creatine and Gastrointestinal Effects in Males and Females · NA · completed
NCT07451496 — PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS) · NA · recruiting

Other recruiting trials for Mild Traumatic Brain Injury

Currently open trials in the same condition.

NCT07246993 — Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms · NA · recruiting
NCT07356167 — Passive Neurosensory Reintegration Training as a Tool to Augment Mild Traumatic Brain Injury · NA · recruiting
NCT07097792 — Concussion Recovery and Support Program · NA · recruiting
NCT06956417 — REhabilitation of MEMory Symptoms After BRain Concussion · NA · recruiting
NCT06217575 — Brain Research Assessing Impacts of Neurophysiological Processing Speed Training in Veterans · NA · recruiting

Other Psychiatric Research Unit, Region Zealand, Denmark trials

Trials by the same sponsor.

NCT06655610 — External Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder - Feasibility Trial · NA · recruiting
NCT05172375 — Development of a Model for Shared Care in the Interface Between General Practice and Mental Health Care · NA · unknown
NCT05243160 — Medication Reviews in Severe Mental Illness · NA · completed
NCT05018312 — Modified Collaborative Assessment VS Standard Assessment on Readiness For Psychotherapy Among Patients With Anxiety · NA · unknown
NCT05516238 — Systematic Use of Telepsychiatry for Outpatients · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05562232 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Psychiatric Research Unit, Region Zealand, Denmark
Last refreshed: 12 July 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05562232.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing